347850 — DND Pharmatech Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩3tn
- KR₩3tn
- KR₩4bn
Annual cashflow statement for DND Pharmatech, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -72,047 | -163,513 | 4,494 | -30,357 | -24,901 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 2,416 | 99,231 | -13,690 | 7,968 | -4,168 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 5,785 | -2,541 | -4,350 | -4,943 | 2,400 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -51,945 | -53,083 | -9,117 | -21,805 | -21,139 |
| Capital Expenditures | -2,218 | -719 | -45.2 | -416 | -64.4 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 263 | 240 | 313 | -124 | -25.8 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,955 | -479 | 268 | -540 | -90.2 |
| Financing Cash Flow Items | 9,077 | 3,217 | -4.67 | 0 | 19,581 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 67,692 | 1,986 | -630 | 36,251 | 24,195 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 15,346 | -50,454 | -9,862 | 14,372 | 2,870 |